Chiusura precedente | 8,90 |
Aperto | 9,15 |
Denaro | 8,99 x 200 |
Lettera | 9,11 x 200 |
Min-Max giorno | 8,87 - 9,13 |
Intervallo di 52 settimane | 3,87 - 11,85 |
Volume | |
Media Volume | 59.462 |
Capitalizzazione | 148,515M |
Beta (5 anni mensile) | 1,27 |
Rapporto PE (ttm) | 20,52 |
EPS (ttm) | 0,44 |
Prossima data utili | 25 apr 2024 - 29 apr 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | N/D |
NEWARK, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2023 before the market opens on Thursday, October 26, 2023. Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on October 26, 2023. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our invest
NEWARK, N.Y., July 27, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2023 with the following highlights: Sales of $42.7 million representing a 32.9% year-over-year increaseOperating income of $3.7 million compared to $0.8 million for the 2022 second quarterAdjusted EPS of $0.29 compared to $0.03 for the 2022 second quarterAdjusted EBITDA of $6.3 million or 14.7% of sales versus $2.2 million or 6.8% last yearBacklog
NEWARK, N.Y., July 13, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2023 before the market opens on Thursday, July 27, 2023. Ultralife’s Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on July 27, 2023. Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor confere